Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.63 |
| ▸ | LAP3 | P28838 | 2/20 | 0.57 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.55 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.55 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.55 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.55 |
| ▸ | FDPS | P14324 | 4/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL304503 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL4529802 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL28902981 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL28679257 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL8377533 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL29037382 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL2745581 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL7124914 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL28882634 | 0.98 | SMPD1 (0.67) | SMPD1LAP3S1PR2S1PR1S1PR3 | |
| SCHEMBL27862599 | 0.96 | SMPD1 (0.65) | SMPD1LAP3S1PR2S1PR1S1PR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2988 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025043082-A2 | COMPOSITIONS AND METHODS TO IMPROVE RNA PROPERTIES USING BASE, PHOSPHODIESTER LINKAGE, SUGAR BACKBONE, AND CAP MODIFICATIONS | THE BROAD INSTITUTE, INC. (US) | 2025-02-27 | — | — | WO | claimed |
| US-20180179541-A1 | Modified L-Nucleic Acid | NOXXON PHARMA AG (DE) | 2018-06-28 | — | — | US | claimed |
| US-20160376594-A1 | Modified L-Nucleic Acid | NOXXON PHARMA AG (DE) | 2016-12-29 | — | — | US | claimed |
| US-9328347-B2 | siRNA useful in the treatment of flavivirus infection | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2016-05-03 | — | — | US | claimed |
| CN-104593122-A | Hydrodynamic drive oil composition for forklift with long service life | JIANGSU LOPAL TECH CO LTD | 2015-05-06 | — | — | CN | claimed |
| US-20150038562-A1 | Modified L-nucleic Acid | NOXXON PHARMA AG (DE) | 2015-02-05 | — | — | US | claimed |
| US-8846631-B2 | MicroRNA compositions and methods | Regulus Therapeutics Inc. (US) | 2014-09-30 | — | — | US | claimed |
| US-20140287023-A1 | 5'-TRIPHOSPHATE OLIGORIBONUCLEOTIDES | UNIV MCGILL (CA) | 2014-09-25 | — | — | US | claimed |
| US-20140248336-A1 | SIRNA USEFUL IN THE TREATMENT OF FLAVIVIRUS INFECTION | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2014-09-04 | — | — | US | claimed |
| WO-2014124433-A1 | 5'-TRIPHOSPHATE OLIGORIBONUCLEOTIDES | OREGON HEALTH & SCIENCE UNIVERSITY (US) | 2014-08-14 | — | — | WO | claimed |
| EP-1071753-A2 | NUCLEIC ACID MOLECULES WITH NOVEL CHEMICAL COMPOSITIONS CAPABLE OF MODULATING GENE EXPRESSION | RIBOZYME PHARMACEUTICALS, INC. (US) | 2001-01-31 | — | — | EP | claimed |
| WO-2000017346-A2 | HAIRPIN HYBRIDIZER MOLECULES FOR MODULATION OF GENE EXPRESSION | RIBOZYME PHARMACEUTICALS, INC. (US) | 2000-03-30 | — | — | WO | claimed |
| WO-2000004141-A2 | USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS | RIBOZYME PHARMACEUTICALS, INC. (US) | 2000-01-27 | — | — | WO | claimed |
| US-5998203-A | PARTICULARLY USEFUL FOR ENZYMATIC CLEAVAGE OF RNA OR SINGLE-STRANDED DNA. | RIBOZYME PHARMACEUTICALS, INC. (US) | 1999-12-07 | — | — | US | claimed |
| WO-1999054459-A2 | NUCLEIC ACID MOLECULES WITH NOVEL CHEMICAL COMPOSITIONS CAPABLE OF MODULATING GENE EXPRESSION | RIBOZYME PHARMACEUTICALS, INC. (US) | 1999-10-28 | — | — | WO | claimed |
| EP-0886641-A2 | SYNTHESIS OF METHOXY NUCLEOSIDES AND ENZYMATIC NUCLEIC ACID MOLECULES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1998-12-30 | — | — | EP | claimed |
| WO-1997026270-A2 | SYNTHESIS OF METHOXY NUCLEOSIDES AND ENZYMATIC NUCLEIC ACID MOLECULES | RIBOZYME PHARMACEUTICALS, INC. (US) | 1997-07-24 | — | — | WO | claimed |
| US-5633111-A | Photoresist composition and article containing 1,2-quinonediazide and an organic phosphorous acid compound | FUJI PHOTO FILM CO., LTD. (JP) | 1997-05-27 | — | — | US | claimed |
| US-5254430-A | Lithographic printing plates | FUJI PHOTO FILM CO., LTD. (JP) | 1993-10-19 | — | — | US | claimed |
| US-5230988-A | Image exposure of plates of aluminum with phosphate or phosphonate compounds and basic compounds | FUJI PHOTO FILM CO., LTD. (JP) | 1993-07-27 | — | — | US | claimed |